Coherent Market Insights: Market Research and B2B Consulting

Detailed Segmentation:

Global Cancer Diagnostics Market, By Test Type (Revenue, USD Bn, 2021 - 2033)

Tumor Biomarkers Tests

PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others

Imaging

Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan

Biopsy

Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others

Liquid Biopsy
Immunohistochemistry
In Situ Hybridization

Global Cancer Diagnostics Market, By Cancer Type (Revenue, USD Bn, 2021 - 2033)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Blood Cancers
- Prostate Cancer
- Ovarian Cancer
- Stomach Cancer
- Liver Cancer
- Others
Global Cancer Diagnostics Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospital Associated Labs
- Independent Diagnostic Laboratories
- Diagnostic Imaging Centers
- Cancer Research Institutes
- Others
Global Cancer Diagnostics, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
  - By Test Type:
    - Tumor Biomarkers Tests
      - PSA Tests
      - CTC Tests
      - AFP Tests
      - CA-19 Tests
      - HER2 Tests
      - BRCA Tests
      - ALK Tests
      - CEA Tests
      - EGFR Mutation Tests
      - KRAS Mutation Tests
      - Others
    - Imaging
      - Ultrasound
      - Mammography
      - MRI Scan
      - PET Scan
      - CT Scan
    - Biopsy
      - Needle Biopsy
      - Endoscopic Biopsy
      - Bone Marrow Biopsy
      - Others
    - Liquid Biopsy
    - Immunohistochemistry
    - In Situ Hybridization
  - By Cancer Type:
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Melanoma
    - Blood Cancers
    - Prostate Cancer
    - Ovarian Cancer
    - Stomach Cancer
    - Liver Cancer
    - Others
  - By End User:
    - Hospital Associated Labs
    - Independent Diagnostic Laboratories
    - Diagnostic Imaging Centers
    - Cancer Research Institutes
    - Others
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Test Type:
    - Tumor Biomarkers Tests
      - PSA Tests
      - CTC Tests
      - AFP Tests
      - CA-19 Tests
      - HER2 Tests
      - BRCA Tests
      - ALK Tests
      - CEA Tests
      - EGFR Mutation Tests
      - KRAS Mutation Tests
      - Others
    - Imaging
      - Ultrasound
      - Mammography
      - MRI Scan
      - PET Scan
      - CT Scan
    - Biopsy
      - Needle Biopsy
      - Endoscopic Biopsy
      - Bone Marrow Biopsy
      - Others
    - Liquid Biopsy
    - Immunohistochemistry
    - In Situ Hybridization
  - By Cancer Type:
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Melanoma
    - Blood Cancers
    - Prostate Cancer
    - Ovarian Cancer
    - Stomach Cancer
    - Liver Cancer
    - Others
  - By End User:
    - Hospital Associated Labs
    - Independent Diagnostic Laboratories
    - Diagnostic Imaging Centers
    - Cancer Research Institutes
    - Others
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Test Type:
    - Tumor Biomarkers Tests
      - PSA Tests
      - CTC Tests
      - AFP Tests
      - CA-19 Tests
      - HER2 Tests
      - BRCA Tests
      - ALK Tests
      - CEA Tests
      - EGFR Mutation Tests
      - KRAS Mutation Tests
      - Others
    - Imaging
      - Ultrasound
      - Mammography
      - MRI Scan
      - PET Scan
      - CT Scan
    - Biopsy
      - Needle Biopsy
      - Endoscopic Biopsy
      - Bone Marrow Biopsy
      - Others
    - Liquid Biopsy
    - Immunohistochemistry
    - In Situ Hybridization
  - By Cancer Type:
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Melanoma
    - Blood Cancers
    - Prostate Cancer
    - Ovarian Cancer
    - Stomach Cancer
    - Liver Cancer
    - Others
  - By End User:
    - Hospital Associated Labs
    - Independent Diagnostic Laboratories
    - Diagnostic Imaging Centers
    - Cancer Research Institutes
    - Others
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Test Type:
    - Tumor Biomarkers Tests
      - PSA Tests
      - CTC Tests
      - AFP Tests
      - CA-19 Tests
      - HER2 Tests
      - BRCA Tests
      - ALK Tests
      - CEA Tests
      - EGFR Mutation Tests
      - KRAS Mutation Tests
      - Others
    - Imaging
      - Ultrasound
      - Mammography
      - MRI Scan
      - PET Scan
      - CT Scan
    - Biopsy
      - Needle Biopsy
      - Endoscopic Biopsy
      - Bone Marrow Biopsy
      - Others
    - Liquid Biopsy
    - Immunohistochemistry
    - In Situ Hybridization
  - By Cancer Type:
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Melanoma
    - Blood Cancers
    - Prostate Cancer
    - Ovarian Cancer
    - Stomach Cancer
    - Liver Cancer
    - Others
  - By End User:
    - Hospital Associated Labs
    - Independent Diagnostic Laboratories
    - Diagnostic Imaging Centers
    - Cancer Research Institutes
    - Others
  - By Country:
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Test Type:
    - Tumor Biomarkers Tests
      - PSA Tests
      - CTC Tests
      - AFP Tests
      - CA-19 Tests
      - HER2 Tests
      - BRCA Tests
      - ALK Tests
      - CEA Tests
      - EGFR Mutation Tests
      - KRAS Mutation Tests
      - Others
    - Imaging
      - Ultrasound
      - Mammography
      - MRI Scan
      - PET Scan
      - CT Scan
    - Biopsy
      - Needle Biopsy
      - Endoscopic Biopsy
      - Bone Marrow Biopsy
      - Others
    - Liquid Biopsy
    - Immunohistochemistry
    - In Situ Hybridization
  - By Cancer Type:
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Melanoma
    - Blood Cancers
    - Prostate Cancer
    - Ovarian Cancer
    - Stomach Cancer
    - Liver Cancer
    - Others
  - By End User:
    - Hospital Associated Labs
    - Independent Diagnostic Laboratories
    - Diagnostic Imaging Centers
    - Cancer Research Institutes
    - Others
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Test Type:
    - Tumor Biomarkers Tests
      - PSA Tests
      - CTC Tests
      - AFP Tests
      - CA-19 Tests
      - HER2 Tests
      - BRCA Tests
      - ALK Tests
      - CEA Tests
      - EGFR Mutation Tests
      - KRAS Mutation Tests
      - Others
    - Imaging
      - Ultrasound
      - Mammography
      - MRI Scan
      - PET Scan
      - CT Scan
    - Biopsy
      - Needle Biopsy
      - Endoscopic Biopsy
      - Bone Marrow Biopsy
      - Others
    - Liquid Biopsy
    - Immunohistochemistry
    - In Situ Hybridization
  - By Cancer Type:
    - Breast Cancer
    - Lung Cancer
    - Colorectal Cancer
    - Melanoma
    - Blood Cancers
    - Prostate Cancer
    - Ovarian Cancer
    - Stomach Cancer
    - Liver Cancer
    - Others
  - By End User:
    - Hospital Associated Labs
    - Independent Diagnostic Laboratories
    - Diagnostic Imaging Centers
    - Cancer Research Institutes
    - Others
  - By Country:
    - South Africa
    - Central Africa
    - North Africa

CANCER DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Detailed Segmentation:

Global Cancer Diagnostics Market, By Test Type (Revenue, USD Bn, 2021 - 2033)

Global Cancer Diagnostics Market, By Cancer Type (Revenue, USD Bn, 2021 - 2033)

Global Cancer Diagnostics Market, By End User (Revenue, USD Bn, 2021 - 2033)

Global Cancer Diagnostics, By Region (Revenue, USD Bn, 2021 - 2033)